Magnus Persson - Dec 20, 2023 Form 4 Insider Report for Avalo Therapeutics, Inc. (AVTX)

Role
Director
Signature
/s/ Christopher Sullivan, by Power of Attorney
Stock symbol
AVTX
Transactions as of
Dec 20, 2023
Transactions value $
$0
Form type
4
Date filed
12/21/2023, 04:05 PM
Previous filing
Jul 5, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AVTX Stock Option (Right to Buy) Award $0 +3.33K $0.00 3.33K Dec 20, 2023 Common Stock 3.33K $0.04 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option will vest in full on December 20, 2024, subject to the Reporting Person's continued service on such vesting date.